Young people who received doses of tisagenlecleucel, a chimeric antigen receptor T cell (CAR-T) therapy, at the higher end of the FDA-approved dosing range had significantly better survival rates at one year compared with ...
Aug 8, 2022
0
12
Researchers at Stanford University have developed "decoy receptor" molecules that inhibit the growth of both multiple myeloma (MM) and diffuse large B cell lymphoma (DLBCL) in mice. The molecules, described in a study to ...
Jul 26, 2022
0
6
A new study has examined the maintenance of memory B cell responses to SARS-CoV-2, the virus that causes COVID-19, after recovery from natural infection or post-vaccination. The study is published in Viral Immunology.
Jul 21, 2022
0
20
In a case study, scientists of the German Center for Infection Research (DZIF) and the University Medical Center Hamburg-Eppendorf investigated the T-cell response of a cancer patient, who was suffering from prolonged COVID-19. ...
Jul 14, 2022
0
30
Antibiotics are among the most powerful superheroes of medicine. From the introduction of penicillin in the 1930s to the dramatic rescues that occur today when doctors use strong antibiotics like vancomycin to combat "superbugs," ...
Jun 15, 2022
0
3
When we're exposed to a pathogen such as a virus, our immune system identifies it as a foreign invader and mounts an attack. This ultimately results in the formation of antibodies which can neutralize the invading pathogen ...
Jun 14, 2022
0
47
A new research paper has been published in Oncotarget, titled "NF-κB over-activation portends improved outcomes in HPV-associated head and neck cancer."
May 25, 2022
0
2
DNA mutations are essential to the rapid development of an array of antibody-producing immune cells called B cells that collectively can recognize a vast number of specific targets. But this process can go awry in people ...
May 25, 2022
0
6
In the majority of cases, children who catch COVID won't end up suffering serious illness. Kids have fewer symptoms, less severe disease, and tend to recover faster than adults.
May 3, 2022
0
7
Chronic lymphocytic leukemia (CLL) is one of the most common blood cancers in adults. The disease originates in B cells—the part of the immune system that produces antibodies—and then evolves slowly, typically affecting ...
Apr 21, 2022
0
38
